Clinical usefulness of the Spanish version of the Clinically Useful Depression Outcome Scale (CUDOS) to determine early response symptoms in patients

Section: Originals

How to quote

Cebrià i Morales Q. Utilidad clínica de la versión española de la Clinically Useful Depression Outcome Scale (CUDOS) para determinar los síntomas de respuesta precoz en pacientes diagnosticados de trastornos del ánimo. Metas Enferm nov 2023; 26(9):25-31. Doi: https://doi.org/MetasEnf.2023.26.1003082176

Authors

Queralt Cebrià i Morales

Position

Doctora por la Universidad Autónoma de Barcelona. Urgencias de Psiquiatría. Hospital de la Santa Creu i Sant Pau. Barcelona (España)

Contact address

Queralt Cebrià i Morales. C/ Garrofer, 53. Urb. Can Rovira Nou. 08186 Lliçà d’Amunt, Barcelona (España).

Contact email: mcebria@santpau.es

Abstract

Objective: to analyse the usefulness in clinical practice of the CUDOS scale (Clinically Useful Depression Outcome Scale) to assess depressive symptomatology and identify early remission symptoms.
Methods: a descriptive longitudinal prospective multicentre study in >18-year-old persons diagnosed with “mood disorder”. The validated versions of CUDOS and EQ-Decentering (the higher the decentering, the lower the depressive symptomatology) were used for data collection; age, gender, level of education, occupational status, civil status, clinical diagnosis and comorbidities were also collected. Multiple regression analysis was conducted with those variables which appeared clinically significant. Finally, the Area under the ROC Curve was calculated, in order to understand the overall performance of the CUDOS scale.
Results: the study included 175 patients; almost 60% of the sample suffered Major Depressive Disorder. The initial mean score in CUDOS was 44.5. The factors predicting early remission identified by Logistic Regression Analysis at Day 4 after admission were: “I thought of a hopeless future” and “I can separate my thoughts and feelings from myself” (EQ-Decentering). The ROC curve analysis showed an Area under the ROC Curve of 0.84.
Conclusions: CUDOS is a tool sensitive to change within short periods of time. The cognitive area items are the first to change during depression improvement. Pessimism regarding the future and the ability for defusion regarding thought and feelings allow to predict who will improve in their next assessment.

Keywords:

Depression; mood disorders; psychometric validation; cut-off scoreresponsiveness to change

Versión en Español

Título:

Utilidad clínica de la versión española de la Clinically Useful Depression Outcome Scale (CUDOS) para determinar los síntomas de respuesta precoz en pacientes diagnosticados de trastornos del ánimo

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, et al. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug Alcohol Depend 2010; 107(2-3):161-70.
  2. Sokero TP, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry 2005; 186:314-8.
  3. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370:851-8.
  4. Gabilondo A, Rojas-Farreras S, Vilagut G, Haro JM, Fernández A, Pinto-Meza A, et al. Epidemiology of major depressive episode in a southern European country: results from the ESEMeD-Spain Project. J. Affect. Disord. 2010; 120:76-85.
  5. Kessler RC, Berglud P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289:3095-105.
  6. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Recurrence of major depressive disorder and its predictors in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med 2013; 43:39-48.
  7. Pichot P (coord.). Diagnostic and statistical manual of mental disorders (DSM). 4th ed. Barcelona: Masson; 1994.
  8. Organización Mundial de la Salud (OMS). CIE-10 Trastornos mentales y del comportamiento. Descripciones clínicas y pautas para el diagnóstico. Madrid: Meditor; 1992.
  9. Lobo A, Pérez-Echeverría MJ, Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med. 1986 Feb; 16(1):135-40.
  10. Vázquez C, Sanz J. Fiabilidad y validez de la versión española del Inventario para la Depresión de Beck de 1978 en pacientes con trastornos psicológicos. Clin Salud. 1999; 10:59-81.
  11. Soler J, Pérez-Sola V, Puigdemont D, Pérez-Blanco J, Figueres M, Álvarez E. Escala para la Depresión del Centro de Estudios Epidemiológicos de la Depresión. Actas Luso Esp Neurol Psiquiatr Cien Afin 1997; 25:243-9.
  12. Hamilton M. A rating scale for depression. J Neurol Neurosurg psychiatry. 1960; 23(1):56-2.
  13. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 1979; 134:382-9.
  14. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV. Do stressful life events predict medical treatment outcome in first episode of depression? Soc Psychatry Psychiatr Epidemiol 2009; 44(9):752-60.
  15. Campayo A, de Jonge P, Roy JF, Saz P, de la Cámara C, Quintanilla MA, et al. ZARADEMP Project. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry 2010; 167(5):580-8.
  16. Vázquez C, Sanz J. Fiabilidad y validez de la versión española del Inventario para la Depresión de Beck de 1978 en pacientes con trastornos psicológicos. Clin Salud. 1999; 10:59-81.
  17. Trujols J, de Diego-Adeliño J, Feliu-Soler A, Iraurgi I, Puigdemont D, Alvarez E, et al. Adaptación castellana del Inventario de Quick de sintomatología depresiva autoadministrado (QIDS-SR16). J. Affect Disord 2014 Dec; 169:189-96.
  18. Kocovski NL, Segal ZV, Battista SR. Mindfulness and psychopathology: problem formulation. En: Didonna F (ed.) In Clinical handbook of mindfulness. New York: Springer; 2009. p. 85-98.
  19. Fresco DM, Segal ZV, Buis T, Kennedy S. Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression. JCCP 2007; 75(3):447-55.
  20. Soler J, Franquesa A, Feliu-Soler A, Cebolla A, García-Campayo J, Tejedor R, et al. Assesing Decentering: Validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample. Behaviour Therapy 2014; 45:863-71. Doi: http://dx.doi.org/10.1016/j.beth
  21. Trujols J, Feliu-Soler A, de Diego-Adeliño J, Portella MJ, Cebrià Q, Soler J, et al. Use of a self-report. A psychometric analysis of the Clinically Useful Depression Outcome Scale (CUDOS) in Spanish patients. J of Affect Disord. 2013 Dec; 151(3):920-3.
  22. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
  23. Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM. Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study. Neuropsychiatr Dis Treat 2015; 11:197-205.
  24. Cameron IM, Crawford JR, Cardy AH, du Toit SW, Lawton K, Hay S, et al. Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care. J Psychiatr Res. 2013; 47:592-8.